dual glp-1/gip receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Design of a novel long-acting

IV hydration therapy is especially beneficial for individuals dealing with dehydration from illness, hangovers, extreme physical activity, or certain chronic conditions like migraines or gastrointestinal disorders

Classically, it should not be used as a screening method for diagnosing asymptomatic patients and its use in patients with signs or symptoms is a subject of debate, given that ammonia is not specific for diagnosing HE

2019;8:bio043182

J Am Coll Cardiol (2006) 47(8 Suppl):C712

Third, monitoring burden where more compounds mean more lab markers to track and more potential variables if something changes

ALC can cross the blood-brain barrier, allowing it to directly influence brain health